Prolonged neuromuscular block after rocuronium in postpartum patients

Anesth Analg. 2002 Mar;94(3):686-9; table of contents. doi: 10.1097/00000539-200203000-00038.

Abstract

Postpartum patients have not completely lost the weight gained during pregnancy. Drug dosing according to total body weight (TBW) can cause exaggerated effects and dosing by lean body mass (LBM) may provide a more consistent response despite the increased weight. We compared the duration of a rocuronium neuromuscular block in 22 women undergoing postpartum tubal ligation 31--79 h after delivery, with that in 22 women undergoing gynecological surgery. Anesthesia was induced and maintained with propofol and alfentanil. Half of the patients in each of the Postpartum and Control groups received a bolus dose of rocuronium 0.6 mg/kg TBW and the remaining half received rocuronium 0.6 mg/kg LBM. Neuromuscular block was monitored by electromyography and the ulnar nerve was stimulated transcutaneously using a train-of-four pattern. When rocuronium was given by TBW, median (range) duration of neuromuscular block until 25% recovery of the first twitch response was longer in the Postpartum group, 35.3 (29.7--48.7) min, compared with the Control group, 24.8 (21.5--28.6) min (P < 0.001). After dosing by LBM, the duration of block was similar between groups. The prolonged block with rocuronium in the Postpartum patients can be explained by relative drug overdose when dose calculation is based on their temporarily increased body weight.

Implications: Neuromuscular block is prolonged in the postpartum period after standard doses of rocuronium. Drug administration according to lean body mass will produce a more consistent duration of block.

MeSH terms

  • Adult
  • Androstanols / pharmacology*
  • Body Weight
  • Female
  • Humans
  • Neuromuscular Junction / drug effects*
  • Neuromuscular Nondepolarizing Agents / pharmacology*
  • Postpartum Period / physiology*
  • Pregnancy
  • Rocuronium
  • Time Factors

Substances

  • Androstanols
  • Neuromuscular Nondepolarizing Agents
  • Rocuronium